US/Silver Spring: Positive-Health, a Wilmington, Delaware establishment, recalls certain batch/lots of Rise Up Red Edition Capsule Dietary Supplements from the American marketplace due to reported undeclared Tadalafil, an FDA approved drug for the treatment of Male Erectile Dysfunction (“ED”), Benign Prostatic Hyperplasia (“BPH”) and certain other medical conditions and in a class of drugs called Phosphodiesterase (“PDE-5”) Inhibitors with consequential risks of dangerous low blood pressure, injury and possible life-changing complications, all serious health and safety hazards.
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Dietary Supplement products are subject to this recall:
Filed under: Dietary Supplements, Drugs, Labeling or regulatory issues, Medical / Veterinary, Tadalafil, US FDA | Tagged: Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia ("BPH"), Dietary Supplements, Male Erectile Dysfunction ("ED"), Positive-Health, Recalls Direct RIN: 15501-2022, Rise Up Red Edition, Rise Up Red Edition Capsule Dietary Supplements, undeclared-Tadalafil-hazard, US FDA, US Food and Drug Administration | Leave a comment »